financetom
Business
financetom
/
Business
/
EV Stocks Are Falling Today: What's Going On?
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
EV Stocks Are Falling Today: What's Going On?
Jan 22, 2025 2:49 PM

Shares of electric vehicle (EV) stocks, including Rivian Automotive Inc. ( RIVN ) and Lucid Group Inc. ( LCID ) , are trading lower amid continued weakness following significant policy changes announced by President Donald Trump.

What To Know: The policy shifts involve revoking a 2021 executive order issued by former President Joe Biden, which set a non-binding target for 50% of new vehicles sold in the U.S. to be electric by 2030.

Trump’s executive order not only eliminates this target but also freezes unspent funds from a $5 billion EV charging infrastructure program. Additionally, the administration plans to reassess emissions regulations requiring automakers to sell between 30% and 56% electric vehicles by 2032 to meet federal standards.

The new policies also raise the possibility of repealing the $7,500 federal tax credit for EV purchases. Furthermore, Trump has expressed intentions to challenge California's waiver, which mandates zero-emission vehicles by 2035 and has been adopted by 11 other states. This could add further uncertainty for EV manufacturers that rely on these mandates to drive adoption.

For Rivian, known for its electric trucks, SUVs and delivery vans, the potential repeal of tax credits and reduced funding for EV infrastructure could dampen demand for its premium-priced vehicles. Lucid, another emerging player in the EV market, faces similar challenges as it contends with reduced government incentives and infrastructure support, critical factors for its growth.

RIVN, LCID Price Actions: Rivian shares were down 4.51% at $12.69 and Lucid shares were down 6.64% at $2.67 at market close Wednesday, according to Benzinga Pro.

Read More:

What’s Going On With Freeport-McMoRan (FCX) Stock Ahead Of Q4 Earnings Report?

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Zevra Therapeutics Files $350 Million Mixed-Shelf; Shares Fall After Hours
Zevra Therapeutics Files $350 Million Mixed-Shelf; Shares Fall After Hours
Jun 4, 2024
05:53 PM EDT, 06/04/2024 (MT Newswires) -- Zevra Therapeutics ( ZVRA ) filed a shelf registration statement with the US Securities and Exchange Commission Tuesday covering the potential sale of up to $350 million of its securities from time to time in one or more offerings. The statement covers the company's common and preferred shares, debt securities and warrants, according...
Cellectis Gets Orphan Drug Label From European Commission For Acute Lymphoblastic Leukemia
Cellectis Gets Orphan Drug Label From European Commission For Acute Lymphoblastic Leukemia
Jun 4, 2024
05:52 PM EDT, 06/04/2024 (MT Newswires) -- Cellectis ( CLLS ) said late Tuesday that the European Commission has granted an orphan drug designation to the company's product candidate UCART22 to treat acute lymphoblastic leukemia. The European Medicines Agency considered the significant benefit of UCART22 has been demonstrated based on the preliminary data generated with UCART22 in heavily pretreated patients...
Vision Sensing Acquisition Files Form 10-Q to Regain Nasdaq Compliance
Vision Sensing Acquisition Files Form 10-Q to Regain Nasdaq Compliance
Jun 4, 2024
05:56 PM EDT, 06/04/2024 (MT Newswires) -- Vision Sensing Acquisition ( VSAC ) filed Tuesday its form 10-Q for the period ended March 31, five days after receiving a noncompliance notice from Nasdaq for the delay. The company said it was given a 60-day period to regain compliance. ...
Phunware Proposes $120 Million Common Stock Offering
Phunware Proposes $120 Million Common Stock Offering
Jun 4, 2024
05:53 PM EDT, 06/04/2024 (MT Newswires) -- Phunware ( PHUN ) said late Tuesday that it is seeking regulatory clearance to sell up to $120 million of its shares through an at-the-market offering. The company, which has filed a prospectus supplement to its existing shelf registration statement, said that no additional capacity is being added to the registration statement as...
Copyright 2023-2026 - www.financetom.com All Rights Reserved